Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

Morie Gertz, Ray Comenzo, Rodney H. Falk, Jean Paul Fermand, Bouke P. Hazenberg, Philip N. Hawkins, Giampaolo Merlini, Philippe Moreau, Pierre Ronco, Vaishali Sanchorawala, Orhan Sezer, Alan Solomon, Giles Grateau

Research output: Contribution to journalArticle

739 Citations (Scopus)

Abstract

We undertook this study to develop uniformly accepted criteria for the definition of organ involvement and response for patients on treatment protocols for immunoglobulin light-chain amyloidosis (AL). A consensus panel was convened comprising 13 specialists actively involved in the treatment of patients with amyloidosis. Institutional criteria were submitted from each, and a consensus was developed defining each organ involved and the criteria for response. Specific criteria have been developed with agreed on definitions of organ and hematologic response as a result of discussions at the 10th International Symposium on Amyloid and Amyloidosis held in Tours, France, April 2004. These criteria now form the working definition of involvement and response for the purposes of future data collection and reporting. We report criteria that centers can now use to define organ involvement and uniform response criteria for reporting outcomes in patients with light-chain AL.

Original languageEnglish (US)
Pages (from-to)319-328
Number of pages10
JournalAmerican Journal of Hematology
Volume79
Issue number4
DOIs
StatePublished - Aug 1 2005

Fingerprint

Immunoglobulin Light Chains
Amyloidosis
Amyloid
Therapeutics
Clinical Protocols
France
Research Design
Light

Keywords

  • Amyloid, organ involvement
  • Amyloid, response to treatment
  • Primary systemic amyloidosis

ASJC Scopus subject areas

  • Hematology

Cite this

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL) : A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. / Gertz, Morie; Comenzo, Ray; Falk, Rodney H.; Fermand, Jean Paul; Hazenberg, Bouke P.; Hawkins, Philip N.; Merlini, Giampaolo; Moreau, Philippe; Ronco, Pierre; Sanchorawala, Vaishali; Sezer, Orhan; Solomon, Alan; Grateau, Giles.

In: American Journal of Hematology, Vol. 79, No. 4, 01.08.2005, p. 319-328.

Research output: Contribution to journalArticle

Gertz, M, Comenzo, R, Falk, RH, Fermand, JP, Hazenberg, BP, Hawkins, PN, Merlini, G, Moreau, P, Ronco, P, Sanchorawala, V, Sezer, O, Solomon, A & Grateau, G 2005, 'Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis', American Journal of Hematology, vol. 79, no. 4, pp. 319-328. https://doi.org/10.1002/ajh.20381
Gertz, Morie ; Comenzo, Ray ; Falk, Rodney H. ; Fermand, Jean Paul ; Hazenberg, Bouke P. ; Hawkins, Philip N. ; Merlini, Giampaolo ; Moreau, Philippe ; Ronco, Pierre ; Sanchorawala, Vaishali ; Sezer, Orhan ; Solomon, Alan ; Grateau, Giles. / Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL) : A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. In: American Journal of Hematology. 2005 ; Vol. 79, No. 4. pp. 319-328.
@article{f7cd1108800b484f907837ccf34682c3,
title = "Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis",
abstract = "We undertook this study to develop uniformly accepted criteria for the definition of organ involvement and response for patients on treatment protocols for immunoglobulin light-chain amyloidosis (AL). A consensus panel was convened comprising 13 specialists actively involved in the treatment of patients with amyloidosis. Institutional criteria were submitted from each, and a consensus was developed defining each organ involved and the criteria for response. Specific criteria have been developed with agreed on definitions of organ and hematologic response as a result of discussions at the 10th International Symposium on Amyloid and Amyloidosis held in Tours, France, April 2004. These criteria now form the working definition of involvement and response for the purposes of future data collection and reporting. We report criteria that centers can now use to define organ involvement and uniform response criteria for reporting outcomes in patients with light-chain AL.",
keywords = "Amyloid, organ involvement, Amyloid, response to treatment, Primary systemic amyloidosis",
author = "Morie Gertz and Ray Comenzo and Falk, {Rodney H.} and Fermand, {Jean Paul} and Hazenberg, {Bouke P.} and Hawkins, {Philip N.} and Giampaolo Merlini and Philippe Moreau and Pierre Ronco and Vaishali Sanchorawala and Orhan Sezer and Alan Solomon and Giles Grateau",
year = "2005",
month = "8",
day = "1",
doi = "10.1002/ajh.20381",
language = "English (US)",
volume = "79",
pages = "319--328",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL)

T2 - A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

AU - Gertz, Morie

AU - Comenzo, Ray

AU - Falk, Rodney H.

AU - Fermand, Jean Paul

AU - Hazenberg, Bouke P.

AU - Hawkins, Philip N.

AU - Merlini, Giampaolo

AU - Moreau, Philippe

AU - Ronco, Pierre

AU - Sanchorawala, Vaishali

AU - Sezer, Orhan

AU - Solomon, Alan

AU - Grateau, Giles

PY - 2005/8/1

Y1 - 2005/8/1

N2 - We undertook this study to develop uniformly accepted criteria for the definition of organ involvement and response for patients on treatment protocols for immunoglobulin light-chain amyloidosis (AL). A consensus panel was convened comprising 13 specialists actively involved in the treatment of patients with amyloidosis. Institutional criteria were submitted from each, and a consensus was developed defining each organ involved and the criteria for response. Specific criteria have been developed with agreed on definitions of organ and hematologic response as a result of discussions at the 10th International Symposium on Amyloid and Amyloidosis held in Tours, France, April 2004. These criteria now form the working definition of involvement and response for the purposes of future data collection and reporting. We report criteria that centers can now use to define organ involvement and uniform response criteria for reporting outcomes in patients with light-chain AL.

AB - We undertook this study to develop uniformly accepted criteria for the definition of organ involvement and response for patients on treatment protocols for immunoglobulin light-chain amyloidosis (AL). A consensus panel was convened comprising 13 specialists actively involved in the treatment of patients with amyloidosis. Institutional criteria were submitted from each, and a consensus was developed defining each organ involved and the criteria for response. Specific criteria have been developed with agreed on definitions of organ and hematologic response as a result of discussions at the 10th International Symposium on Amyloid and Amyloidosis held in Tours, France, April 2004. These criteria now form the working definition of involvement and response for the purposes of future data collection and reporting. We report criteria that centers can now use to define organ involvement and uniform response criteria for reporting outcomes in patients with light-chain AL.

KW - Amyloid, organ involvement

KW - Amyloid, response to treatment

KW - Primary systemic amyloidosis

UR - http://www.scopus.com/inward/record.url?scp=23244448608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23244448608&partnerID=8YFLogxK

U2 - 10.1002/ajh.20381

DO - 10.1002/ajh.20381

M3 - Article

C2 - 16044444

AN - SCOPUS:23244448608

VL - 79

SP - 319

EP - 328

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 4

ER -